Julie Haydon has over 20 years of experience in research, drug development, and quality. She joined Acumen in 2022. Her previous employers were Indiana University School of Medicine, Strand Diagnostics, and AIT Bioscience where she conducted medical and clinical research, DNA analysis, and assay and method development of large molecules. In her previous position she served as Quality Associate II at B2S Life Sciences. She holds a Master of Science degree in Biology from Indiana University-Purdue University Indianapolis.